BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30120165)

  • 1. Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study.
    Kang D; Kim IR; Choi EK; Im YH; Park YH; Ahn JS; Lee JE; Nam SJ; Lee HK; Park JH; Lee DY; Lacouture ME; Guallar E; Cho J
    Oncologist; 2019 Mar; 24(3):414-420. PubMed ID: 30120165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres.
    Chan J; Adderley H; Alameddine M; Armstrong A; Arundell D; Fox R; Harries M; Lim J; Salih Z; Tetlow C; Wong H; Thorp N
    Eur J Cancer Care (Engl); 2021 May; 30(3):e13395. PubMed ID: 33350015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT).
    Kang D; Kim IR; Park YH; Im YH; Zhao D; Guallar E; Ahn JS; Cho J
    Support Care Cancer; 2020 Apr; 28(4):1829-1837. PubMed ID: 31338640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
    JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients.
    Fujii T; Ichiba K; Honda C; Tokuda S; Nakazawa Y; Ogino M; Kurozumi S; Obayashi S; Yajima R; Shirabe K
    Breast Cancer; 2021 Mar; 28(2):329-334. PubMed ID: 32944881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors.
    Bhoyrul B; Asfour L; Lutz G; Mitchell L; Jerjen R; Sinclair RD; Holmes S; Chaudhry IH; Harries MJ
    JAMA Dermatol; 2021 Nov; 157(11):1335-1342. PubMed ID: 34586345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
    Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
    Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies.
    Slaught C; Roman M; Yashar S; Holland V; Goh C
    Cutis; 2021 Mar; 107(3):E17-E22. PubMed ID: 33956617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer.
    Núñez-Torres R; Martín M; García-Sáenz JÁ; Rodrigo-Faus M; Del Monte-Millán M; Tejera-Pérez H; Pita G; de la Torre-Montero JC; Pinilla K; Herraez B; Peiró-Chova L; Bermejo B; Lluch A; González-Neira A
    JAMA Dermatol; 2020 Sep; 156(9):987-991. PubMed ID: 32756886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced irreversible alopecia in early breast cancer patients.
    Kim GM; Kim S; Park HS; Kim JY; Nam S; Park S; Kim SI; Kim D; Sohn J
    Breast Cancer Res Treat; 2017 Jun; 163(3):527-533. PubMed ID: 28324267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia.
    Freites-Martinez A; Chan D; Sibaud V; Shapiro J; Fabbrocini G; Tosti A; Cho J; Goldfarb S; Modi S; Gajria D; Norton L; Paus R; Cigler T; Lacouture ME
    JAMA Dermatol; 2019 Jun; 155(6):724-728. PubMed ID: 30840033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of chemotherapy-induced alopecia in childhood.
    Choi M; Kim MS; Park SY; Park GH; Jo SJ; Cho KH; Lee JW; Park KD; Shin HY; Kang HJ; Kwon O
    J Am Acad Dermatol; 2014 Mar; 70(3):499-505. PubMed ID: 24355411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
    Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
    Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients.
    Fonia A; Cota C; Setterfield JF; Goldberg LJ; Fenton DA; Stefanato CM
    J Am Acad Dermatol; 2017 May; 76(5):948-957. PubMed ID: 28284826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
    JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.
    Marks DH; Okhovat JP; Hagigeorges D; Manatis-Lornell AJ; Isakoff SJ; Lacouture ME; Senna MM
    Breast Cancer Res Treat; 2019 Jun; 175(2):267-276. PubMed ID: 30806923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients.
    Ohsumi S; Kiyoto S; Takahashi M; Takashima S; Aogi K; Shimizu S; Doi M
    Support Care Cancer; 2021 Oct; 29(10):6119-6125. PubMed ID: 33797582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens.
    Chan A; Bauwens A; Pontre S; Jackson S; McGlone F; Ernenwein T; Chih J; Reid C
    Breast; 2018 Oct; 41():127-132. PubMed ID: 30048865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent chemotherapy-induced alopecia: case report and review of the literature.
    Tallon B; Blanchard E; Goldberg LJ
    J Am Acad Dermatol; 2010 Aug; 63(2):333-6. PubMed ID: 20471136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience.
    Prochilo T; Huscher A; Andreis F; Mirandola M; Zaina E; Pomentale B; Pedrali C; Zanotti L; Mutti S; Zaniboni A
    Rev Recent Clin Trials; 2019; 14(1):66-71. PubMed ID: 30457055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.